Ted Kellner Issues Letter to AIM ImmunoTech (AIM)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Ted Kellner Issues Letter to AIM ImmunoTech (AIM)

AIM’s Clinical Strategy Under Incumbent Board Has Totally Failed

December 11, 2024 7:30 AM EST

Incumbent Boards Claims of Progress Are Not Credible or Supported by Data

AIM Maintains Relationship with CRO Co-Founded by a Convicted Felon Who Deceived Investors about the Timeline and Status of Regulatory Submissions to the U.S. FDA

According to ISS The lack of transparency gives the impression that the companys pipeline is more advanced and that the company is more involved than it actually is1

Kellner Group Owns 5.04% of Outstanding Shares and is Fully Aligned with... More